N
Nexstim Oyj
OMXH:NXTMH
Nexstim Oyj
OMXH:NXTMH
Price:
10.7
EUR
5.94%
Market Closed
Market Cap:
€77.1m
Relative Value
The Relative Value of one NXTMH stock under the Base Case scenario is 6.64 EUR. Compared to the current market price of 10.7 EUR, Nexstim Oyj is Overvalued by 38%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NXTMH
Relative Value
Base Case
6.64
EUR
Overvaluation 38%
N
Multiples Across Competitors
NXTMH Competitors Multiples
Nexstim Oyj Competitors
Nexstim Oyj Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FI |
N
|
Nexstim Oyj
OMXH:NXTMH
|
76.9m EUR | 7.6 | -271.6 | 75.6 | 944.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
201.9B USD | 4.6 | 31 | 17.7 | 24.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD | 17.7 | 62.5 | 47.5 | 58.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD | 5.9 | 45.6 | 23 | 27.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
125B USD | 3.5 | 27.1 | 14.7 | 21.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.6B USD | 5.7 | 39.2 | 22.9 | 30.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.8B EUR | 2 | 22.5 | 12.4 | 17.4 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.6B USD | 12.2 | 49.6 | 35.2 | 39 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD | 2.3 | 28.6 | 11 | 18.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD | 8.3 | 46.8 | 25.8 | 28.3 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD | 1.9 | 18.4 | 13 | 15.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
